Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors

Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors

US Patent 8148396 · Granted Apr 3, 2012

Estimated economic value: $29,783,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alph2025
Isoxazole carboxylic acids as LPA antagonists2025
Substituted phenyl oxazolone compounds2025
Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof2025
Triazole n-linked carbamoyl cyclohexyl acids as LPA antagonists2025
Soap dispenser2024
Substituted phenyloxazolidinones for antimicrobial therapy2024
Modulating Nudix homology domain (NHD) with nicotinamide mononucleotide analogs 2024
Cyclic dinucleotides as anticancer agents2024
5A5B6C tricyclic spirolactone derivative, preparation method therefor and use th2023
Triazole N-linked carbamoyl cyclohexyl acids as LPA antagonists2023
Cyclic dinucleotides as anticancer agents2023